Endocrine Hypertension Essential hypertension92-94% Secondary hypertension6-8% Renal4-5% Miscellaneous~2% Endocrine 1-2% Primary hyperaldosteronism 0.3-15%

Slides:



Advertisements
Similar presentations
Incidental Adrenal Mass
Advertisements

Adrenocortical Functions - 2. Adrenocortical hypofunction Adrenocortical insufficiency may be: A.Primary B.Secondary.
A Case From The Clinic Paul J. Scheel, Jr., MD Director Of Nephrology The Johns Hopkins University School of Medicine.
Adrenal Incidentaloma: An Update of its Management 18 th September 2004 Dominic Tai Division of Urology Department of Surgery Pamela Youde Nethersole Eastern.
Three Children with Electrolyte Problems by Larry Greenbaum, MD, PhD Pediatric Nephrology by Larry Greenbaum, MD, PhD Pediatric Nephrology.
Mineralocorticoid Excess Hyperaldostronism. Epidemiology first description of a patient with an aldosterone-producing adrenal adenoma (Conn's syndrome)
Adrenal Incidentaloma
Surgical Disease of the Adrenal Gland (Part I)
Adrenals Dr.Areej A. Bokhari, MD Scc-Surg
Adrenal gland Omar benhusain Supervised by Dr. Abdulaziz Al-Saif.
Adrenal Masses: Differential Dx and Work-up Sara Faber August 4, 2008.
Dr. Saleh M. Aldaqal MBBS, FRCSI,SBGS Assistant Professor and Consultant General And laparoscopic Surgery(france), Department of Surgery, Faculty of Medicine,
Epidemic of Primary Hyperaldosteronism: Facts and Myths Carla Sawan, MD Division of Endocrinology Saint George Hospital University Medical Center, Beirut.
Office Evaluation of Hypertension December 2, 2008.
Focus on Addison’s Disease
Endocrine hypertension
Case #5 Ephraim R. Caangay Pharmacology B February 7, 2007.
CLINICAL APPROACHES TO SECONDARY HYPERTENSION. DEFINITION Essential, primary, or idiopathic hypertension is defined as high BP in which secondary causes.
Adrenal gland  The adrenal cortex produces three major classes of steroids: (1) glucocorticoids (2)mineralocorticoids (3) adrenal androgens.
Secondary Hypertension: Adrenal and Nervous Systems Ανδρέας Πιτταράς Καρδιολόγος Καρδιολόγος Clinical Hypertension Specialist ESH Υπερτασικό ιατρείο Τζάνειο.
How to recognize the different faces of Hypertension
“Dillinger” Duckworth 11yo MN Siberian Husky MR#
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division, Department of Medicine in King Saud University.
بیماریهای ادرنال. Endocrine Hypertension Hypertension (HT) is the most prevalent cardiovascular disorder and a major public health problem in the United.
 Learning objectives:  The student should:  Recognize the variants of hyperadrenalism  Recognize the variants of hypoadrenalism  Understand the histopathological.
Pheochromocytoma. Pheochromocytomas and paragangliomas are catecholamine- producing tumors derived from the sympathetic or parasympathetic nervous system.
Cushing’s Syndrome.
Check your knowledge in… Adrenal diseases. Which treatment is indicated in case of hyperaldosteronism due to adrenal hyperplasia? 1.Medical treatment.
Case 1 49 yo male with hypertension on a potassium-sparing diuretic.
This lecture was conducted during the Nephrology Unit Grand Ground by Registrar under Nephrology Division under the supervision and administration of Prof.
Endocrine Post Clinic Conference September 2, yo man with hypertension.
Armed Forces Academy of Medical Sciences
Primary Aldosteronism Paul S. Kellerman, M.D., FACP Associate Professor Division of Nephrology.
Physiology of Adrenal Medulla Dr. Eman El Eter. A case study? “Rollie Hendrix,” a 35-year-old husband and father of three children, has been experiencing.
 Cardiovascular Effects  α -receptor antagonist drugs lower peripheral vascular resistance and blood pressure.  These drugs can prevent the pressor.
Although in more than 90% of patients with high blood pressure no underlying causes could be identified, up to 10% of hypertensives have a secondary.
MRI scan shows a 3- cm low- density suprarenal mass on the right side.
Evaluation and Management of the Patient with Hypertension and Hypokalemia Stephen L. Aronoff, MD.
Disorders of the adrenal glands
Adrenal Cortical Hormones
HYPERTENSION Lesley Ashby. DEFINITION NICE define hypertension as persistent raised blood pressure above 140/90 mmHg NICE define hypertension as persistent.
Cardiovascular & Renal Endocrinology ©  IOS/S Nussey.
Section VI. Endocrine Hypertension
SECONDARY HYPERTENSION
Introduction Pheochromocytomas are rare neuroendocrine tumors arising from catecholamine-producing cells in the adrenal medulla. Prevalence ranges from.
Adrenal (Suprarenal )Medulla Dr Taha Sadig Ahmed.
Endocrine Physiology The Adrenal Medulla, Pheochromocytoma Dr. Khalid Alregaiey.
Adrenal Physiology David Feldman Glucocorticoids Mineralocorticoids Catecholamines/Adrenal Medulla Adrenal Causes of Hypertension ◦ Cushings Syndrome ◦
Arthur S. Schneider, M.D. Department of Pathology
Pathology of Adrenal Cortex II
Paraganglioma (Extraadrenal pheochromocytoma) 수요증례 Review
MINERALOCORTICOIDS Dr. Eman El Eter. Hormones of Adrenal gland  Cortex: (Secretes steroid hormones)  Glucocorticoids.  Mineralocorticoids.  Androgens.
Resistant Hypertension - Primary Aldosteronism - 내분비 대사 내과 R3 송 란.
بسم الله الرحمن الرحيم.
Adrenal gland hyperfunction
DOC secreting adrenal adenoma, a rare cause of hypertension
A 30-year-old woman had a 7-year history of hypertension and hypokalemia. Her blood pressure was not well controlled despite a four-drug program that included.
Dr. M. SOFI MD; FRCP (London); FRCPEdin; FRCSEdin
Asymptomatic paraganglioma
MEDULLARY THYROID CANCER
DISEASES OF THE ENDOCRINE SYSTEM SUPRARENAL GLAND
بسم الله الرحمن الرحيم.
Abdulrhman M. AlOmair Group: 4 Hypertension
Adrenal Disorders - Some Common Questions Family Practice Refresher Course April 20, 2017 Janet A. Schlechte, M.D.
Dr. M. SOFI MD; FRCP (London); FRCPEdin; FRCSEdin
Unit IV – Problem 5 – Clinical Disease of Adrenal Gland
K. Poppe Endocrinologie
Endocrinology: Adrenal Disorders
SUMMARY OF ADRENAL IMAGING
Diseases of adrenal cortex & medulla
Presentation transcript:

Endocrine Hypertension Essential hypertension92-94% Secondary hypertension6-8% Renal4-5% Miscellaneous~2% Endocrine 1-2% Primary hyperaldosteronism % Cushing’s syndrome <0.1% Pheochromocytoma <0.1%

Endocrine Hypertension Mineralocorticoid excess Cushing’s syn. Pheochromocytoma

Sympathetic Nervous System

CA Synthesis & Metabolism Epinephrine Norepinephrine Metanephrine Normetanephrine COMT MAO Vanylmandelic Acid (VMA) APUD cells Tyrosine Hydroxylase AADC Dopamine β Hydroxylase PNMT

Pheochromocytoma ~ 0.1% or less of hypertension Extraadrenal- Paraganglioma “10% Tumor” Bilateral Extra-adrenal Familial(? ~20%) Malignant

Pheochromocytoma Symptoms During paroxysm: Between attacks: Headache Sweating Sweating Cold hands & feet Palpitations Weight loss Tremor Constipation Chest pain Abdominal pain Nausea, vomiting

Pheochromocytoma Signs:   Increased blood pressure   Orthostatic hypotension   Tachycardia

Pheochromocytoma Syndromic- Multiple Endocrine Neoplasia Type 2 (A & B) Multiple Endocrine Neoplasia Type 1 (rarely) von Hippel-Lindau disease Neurocutaneous syndromes (NF1) Non- syndromic SDHB, C, D; TEM127 Familial forms: (germ-line mutations autosomal dominant )

When to Suspect a Pheochromocytoma?  Episodic HTN accompanied by the classical triad  Refractory HTN  Labile HTN  Severe pressor response to surgery etc.  Familial Hx associated with Pheo  Incidental adrenal mass  HTN at a young age  Takotsubo cardiomyopathy

MEN2  MEN 2A  MEN 2B  Familial Medullary Thyroid Carcinoma (FMTC) 10-20% היפרפרהטירוידיזם 40-50% קרצינומה מדולארית של בלוטת התריס 90% פאוכרומוציטומה 40-50% 100% 90%

MEN2b מראה מרפנואידי נוירומות בריריות

Von-Hippel Lindau Disease  Renal cell carcinoma  Retinal angioma  Cerebellar or spinal hemangioblastoma hemangioblastoma  Pheochromocytoma-7-19%.

 24 hour urine collection for free CATs  epinephrine and norepinephrine  Sensitivity ~70%  24 hour urine collection for CAT metabolites (METS)  metanephrine, normetanephrine and acid  More specific, sensitivity >90%  Urinary CATS + METS  Sensitivity > 95%  Plasma free metanephrines.  Highest sensitivity > 95% Pheochromocytoma- Biochemical Diagnosis

Only after the Dx of pheo is biochemically confirmed!!  CT  MRI  I 123 MIBG  PET- 18 FDG  Octreoscan or 68 Ga-DOTATATE-PET Pheochromocytoma imaging

Malignant pheo- 68 Ga-DOTATATE Scan

Pheochromocytoma- Therapy Surgical resection of tumor-   If localized to adrenal- laparoscopic adrenalectomy Prior to surgery-   Hypertension: α-blockade (phenoxybenzamine, doxasocin, phentolamine)   Tachycardia- β-blockade (only after α blockade)

Mineralocorticoid excess

Biosynthesis and action of Aldosterone Glomerulosa ANDROSTENDIONE cortisol cortisone 11 β HSD type 2 Kidney

Renin-Angiotensin- Aldosterone Regulatory System ↑ACTH Sympathetic stimulation

Mineralocorticoid Excess HyperaldosteronismPrimarySecondary Apparent MC excess ↓PRA and ↓ PAC ↓PRA and ↓ PAC

Hyperaldosteronism DD: Primary-  PRA Secondary-  PRA 1. Renal Artery Stenosis (atherosclerosis, fibromuscular dysplasia). 1. Renal Artery Stenosis (atherosclerosis, fibromuscular dysplasia). 2. Primary tumor of the JGA 2. Primary tumor of the JGA

Primary Aldosteronism Described by Conn in 1955.Described by Conn in Hypertension, hypokalemia, metabolic alkalosis.Hypertension, hypokalemia, metabolic alkalosis. Prevalence: 5-15% of patients with hypertension.Prevalence: 5-15% of patients with hypertension.

Causes of Primary Aldosteronism Aldosterone Producing Adenoma (APA) ~30% Idiopathic/hyperplasia (IHA) ~ 70% Adrenocortical Carcinoma rare

Clinical Presentation Hypertension Moderate to severe (APA>hyperplasia) Moderate to severe (APA>hyperplasia) Refractory to medications Refractory to medications  K on low dose diuretics  K on low dose diuretics End-organ damage (aldosterone, HTN) LVH LVH Micro and macro vascular disease Micro and macro vascular disease

Clinical Presentation  Laboratory  K, ↔K  K, ↔K Metabolic alkalosis Metabolic alkalosis Mild  Na Mild  Na  Symptoms related to hypokalemia Neuromuscular Neuromuscular Nephrogenic DI (polyuria & nocturia) Nephrogenic DI (polyuria & nocturia)

Screening for Primary Hyperaldosteronism  Hypertension and hypokalemia (including patients treated with low dose diuretics).  Severe, resistant, or relatively acute hypertension, age<30.  An adrenal incidentaloma

Diagnosis: Screening testScreening test Confirmatory testingConfirmatory testing Determine the subtypeDetermine the subtype

Screening Tests for Primary Aldosteronism: PAC/PRA (PAC >20 ng/dl, PRA 20 ng/dl, PRA<1 ng/ml/h)  >30 suggestive; >50 diagnostic  Morning, ambulatory, paired, random PAC and PRA.  Serum K levels should be normalized  Not under beta blockers and spironolactone (preferably also w/o ACE inhibitors).

Diagnosis  Confirmatory tests : Saline infusion test- non suppressed aldo. Saline infusion test- non suppressed aldo. 24 hour urinary aldosterone 24 hour urinary aldosterone  Determining subtype: Posture test- Posture test- normal response: elevation of Aldo normal response: elevation of Aldo IHA- normal response IHA- normal response APA- no elevation APA- no elevation

Imaging Only after biochemical Dx (2-10% nonfunctioning adenomas on CT).Only after biochemical Dx (2-10% nonfunctioning adenomas on CT). Abdominal spiral CTAbdominal spiral CT In patients > 40 years of age- Selective adrenal venous samplingIn patients > 40 years of age- Selective adrenal venous sampling

Treatment  APA- Unilateral total adrenalectomy  IHA- Medical management (aldactone, amiloride, aplerenone) (aldactone, amiloride, aplerenone)

> 30

Other Causes for Endocrine HTN  Hypothyroidism –diastolic HTN  Hyperthyroidism- systolic HTN  Acromegaly- salt retention  Hyperparathyroidism